Preventative healthcare powers new wave of UK regulatory reform
Speakers at the 2026 DIA-MHRA Global Summit talked of a healthcare system overhaul with preventative medicine at the centre, and…
Speakers at the 2026 DIA-MHRA Global Summit talked of a healthcare system overhaul with preventative medicine at the centre, and…
MSD inks this deal as it looks to offset the looming impact of Keytruda’s patent expiry and secure its long-term…
Speakers at the 2026 DIA-MHRA Global Summit talked of a healthcare system overhaul with preventative medicine at the centre, and…
MSD inks this deal as it looks to offset the looming impact of Keytruda’s patent expiry and secure its long-term…
Executives from Thermo Fisher, Fujifilm and Recipharm outline CDMOs’ uses of, and considerations for, artificial intelligence.
Novartis has earmarked pipeline assets with multi-billion-dollar sale peaks as it tackles a wave of patent expirations.
Insmed’s shares spiked 20% following these rumours, while Sanofi’s stock dropped 2%, despite analysts backing the potential deal rationale.
Merz Therapeutics' CEO Stefan König discusses the company's growth ambitions, neuroscience pipeline and expanding opportunities in China.
The AI-driven biotech has secured FDA alignment on a pivotal trial for its FAP therapy, with a study start planned…
Despite substantial M&A activity and capital availability, some companies are struggling to get deals over the line.
The oncology biotech could go public in a SPAC reverse takeover, though an IPO is not guaranteed.
Lineage hopes that hNSC-01, a novel cell therapy, could offer symptomatic and disease-slowing benefits in Huntington’s.